Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
McCormick CEO: Macro Concerns Continue to Weigh on Consumer Confidence -- Market Talk

McCormick CEO: Macro Concerns Continue to Weigh on Consumer Confidence -- Market Talk

Dow JonesDow Jones2026/10/01 12:00

0800 ET - McCormick continues to operate in a dynamic environment, CEO Brendan Foley says in prepared earnings remarks. "Geopolitical volatility, elevated fuel costs, and persistent inflation continue to influence consumer confidence and spending," he says. "In the U.S., higher gas prices and the Cyclospora outbreak have added pressure and contributed to softer traffic across foodservice and grocery channels." Within this environment, consumers are looking for practical ways to manage budgets, Foley says, including using what's in their pantries, repurposing leftovers and seeking simple, affordable ways to add flavor at home. (connor.hart@wsj.com)

(END) Dow Jones Newswires

October 01, 2026 08:00 ET (12:00 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Yen appreciation and global bond slump lead Japan GPIF to first loss in six quarters, with almost no asset allocation adjustment

According to the latest quarterly report from Japan’s Government Pension Investment Fund (GPIF), its asset allocation remained almost unchanged from its model portfolio for the three months ending in late September. However, the fund recorded a 1.7% quarterly loss during this period—the first loss in six quarters—due to a global slump in bond prices and the appreciation of the yen.

智通财经•2026/11/06 08:27

GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions

Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.

智通财经•2026/11/06 07:56

Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.

After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.

智通财经•2026/11/06 07:53